Lion Biotechnologies Inc (LBIO)

6.15
0.35 5.38
NASDAQ : Health Care
Prev Close 6.50
Open 6.55
Day Low/High 6.00 / 6.55
52 Wk Low/High 4.24 / 10.15
Volume 282.08K
Avg Volume 279.80K
Exchange NASDAQ
Shares Outstanding 62.35M
Market Cap 399.05M
EPS -3.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of Upcoming Deadline To File Lead Plaintiff Papers In Lion Biotechnologies, Inc. (NASDAQ:LBIO) Securities Case

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of Upcoming Deadline To File Lead Plaintiff Papers In Lion Biotechnologies, Inc. (NASDAQ:LBIO) Securities Case

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that June 13, 2017 is the last day to file lead plaintiff papers in the securities lawsuit...

Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme

Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme

Lion Biotechnologies, XBiotech and Halozyme Therapeutics were among the biotech movers in premarket trading on Friday.

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Lion Biotechnologies, Inc.

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Lion Biotechnologies, Inc.

Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Lion Biotechnologies, Inc.

Robbins Arroyo LLP: Lion Biotechnologies, Inc. (LBIO) Misled Shareholders According To A Recently Filed Class Action

Robbins Arroyo LLP: Lion Biotechnologies, Inc. (LBIO) Misled Shareholders According To A Recently Filed Class Action

Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Lion Biotechnologies, Inc.

Lion Biotechnologies Enters Oversold Territory (LBIO)

Lion Biotechnologies Enters Oversold Territory (LBIO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of Upcoming Deadline To File Lead Plaintiff Papers In Lion Biotechnologies, Inc. (LBIO) Securities Case

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of Upcoming Deadline To File Lead Plaintiff Papers In Lion Biotechnologies, Inc. (LBIO) Securities Case

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that June 13, 2017 is the last day to file lead plaintiff papers in the securities lawsuit...

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Lion Biotechnologies, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Lion Biotechnologies, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf...

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Lion Biotechnologies, Inc. To Contact The Firm

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Lion Biotechnologies, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Lion Biotechnologies, Inc.

Short Interest In Lion Biotechnologies Drops 30.6%

Short Interest In Lion Biotechnologies Drops 30.6%

The most recent short interest data has been released for the 04/13/2017 settlement date, which shows a 1,181,308 share decrease in total short interest for Lion Biotechnologies Inc , to 2,683,777, a decrease of 30.56% since 03/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Glancy Prongay & Murray Announces The Filing Of A Securities Class Action On Behalf Of Lion Biotechnologies, Inc. Investors And Encourages Investors To Contact The Firm

Glancy Prongay & Murray Announces The Filing Of A Securities Class Action On Behalf Of Lion Biotechnologies, Inc. Investors And Encourages Investors To Contact The Firm

Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit has been filed on behalf of investors who purchased Lion Biotechnologies, Inc.

LBIO LOSS NOTICE: Rosen Law Firm Reminds Lion Biotechnologies, Inc. Investors Of Important First Filed Class Action - LBIO

LBIO LOSS NOTICE: Rosen Law Firm Reminds Lion Biotechnologies, Inc. Investors Of Important First Filed Class Action - LBIO

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Lion Biotechnologies, Inc.

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Lion Biotechnologies, Inc. And Encourages Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Lion Biotechnologies, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Lion Biotechnologies, Inc.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Lion Biotechnologies, Inc.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Lion Biotechnologies, Inc.

Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of Lion Biotechnologies, Inc.

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Lion Biotechnologies, Inc. Investors

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Lion Biotechnologies, Inc. Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Lion Biotechnologies, Inc.

INVESTOR ALERT: Khang & Khang LLP Announces An Investigation Of Lion Biotechnologies, Inc. And Encourages Investors With Losses To Contact The Firm

INVESTOR ALERT: Khang & Khang LLP Announces An Investigation Of Lion Biotechnologies, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Lion Biotechnologies, Inc.

Notable Wednesday Option Activity: LBIO, STMP, ZIOP

Notable Wednesday Option Activity: LBIO, STMP, ZIOP

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Lion Biotechnologies Inc , where a total of 2,000 contracts have traded so far, representing approximately 200,000 underlying shares. That amounts to about 69.5% of LBIO's average daily trading volume over the past month of 287,740 shares.